Novel PET tracers: added value for endocrine disorders.

Dihydroxyphenylalanine / analogs & derivatives Endocrine System Diseases / diagnostic imaging Fluorodeoxyglucose F18 Gallium Radioisotopes Humans Neuroendocrine Tumors / diagnostic imaging Positron-Emission Tomography Radiopharmaceuticals
18F-Choline 18F-FDG 18F-FDOPA Gallium-68 Neuroendocrine tumors PET/CT Primary hyperparathyroidism Somatostatin

Journal

Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444

Informations de publication

Date de publication:
04 2019
Historique:
received: 13 01 2019
accepted: 05 03 2019
pubmed: 16 3 2019
medline: 21 4 2020
entrez: 16 3 2019
Statut: ppublish

Résumé

Nuclear medicine has been implicated in the diagnosis and treatment of endocrine disorders for several decades. With recent development of PET tracers, functional imaging now plays a major role in endocrine tumors enabling with high performance to their localization, characterization, and staging. Besides

Identifiants

DOI: 10.1007/s12020-019-01895-z PMID: 30875057
pubmed: 30875057
doi: 10.1007/s12020-019-01895-z
pii: 10.1007/s12020-019-01895-z
doi:

Substances chimiques

Gallium Radioisotopes 0
Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D
fluorodopa F 18 2C598205QX
Dihydroxyphenylalanine 63-84-3
Gallium-68 98B30EPP5S

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

14-30

Références

Eur J Nucl Med. 2001 Jan;28(1):64-71
pubmed: 11202454
Medicine (Baltimore). 2015 Oct;94(41):e1701
pubmed: 26469908
Nucl Med Commun. 2009 Apr;30(4):281-6
pubmed: 19247211
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):943-66
pubmed: 23417499
J Nucl Med. 2016 Feb;57(2):186-91
pubmed: 26564322
Clin Nucl Med. 2014 Jun;39(6):e328-30
pubmed: 24152627
Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S27-51
pubmed: 22005114
J Cell Physiol. 2017 Feb;232(2):270-275
pubmed: 27381438
Abdom Imaging. 2013 Jun;38(3):552-60
pubmed: 22743840
Eur Radiol. 2009 Jun;19(6):1425-34
pubmed: 19156423
Langenbecks Arch Surg. 2011 Jan;396(1):83-90
pubmed: 21061130
Neuroendocrinology. 2018;106(3):274-282
pubmed: 28803235
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1772-1780
pubmed: 29680989
Acta Oncol. 2016;55(1):3-14
pubmed: 26223571
Eur Radiol. 2011 Nov;21(11):2408-16
pubmed: 21750886
Clin Endocrinol (Oxf). 2004 Sep;61(3):299-310
pubmed: 15355445
Eur J Nucl Med Mol Imaging. 2003 May;30(5):689-94
pubmed: 12618904
Dig Dis Sci. 2012 Jan;57(1):9-18
pubmed: 21938486
Pathologe. 2014 May;35(3):283-93; quiz 294
pubmed: 24671468
Nucl Med Commun. 2012 Jul;33(7):775-9
pubmed: 22546877
Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1800-8
pubmed: 24072345
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):897-907
pubmed: 23460395
Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1431-8
pubmed: 18418596
J Clin Endocrinol Metab. 2007 Nov;92(11):4185-90
pubmed: 17726071
Lancet Diabetes Endocrinol. 2013 Oct;1(2):115-22
pubmed: 24622317
J Clin Endocrinol Metab. 2009 Dec;94(12):4757-67
pubmed: 19864450
J Clin Endocrinol Metab. 2005 Nov;90(11):6077-84
pubmed: 16091497
J Nucl Med. 2014 Mar;55(3):367-72
pubmed: 24343986
Q J Nucl Med Mol Imaging. 2016 Mar;60(1):69-76
pubmed: 24740163
Nuklearmedizin. 2008;47(4):158-62
pubmed: 18690375
J Clin Endocrinol Metab. 2014 Dec;99(12):4531-6
pubmed: 25215560
Eur J Nucl Med Mol Imaging. 2015 May;42(6):868-76
pubmed: 25676472
Ann Pathol. 2011 Apr;31(2):88-92
pubmed: 21601112
Ann Oncol. 2012 Oct;23 Suppl 7:vii110-9
pubmed: 22997443
Int J Oncol. 2014 Oct;45(4):1531-6
pubmed: 25096059
Cancer. 2008 Jul 1;113(1):5-21
pubmed: 18473355
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1486-90
pubmed: 27118126
J Nucl Med. 2016 May;57(5):715-20
pubmed: 26795291
J Clin Endocrinol Metab. 2007 Dec;92(12):4590-7
pubmed: 17878252
Clin Cancer Res. 2015 Sep 1;21(17):3888-95
pubmed: 25873086
J Nucl Med. 2009 Jun;50(6):858-64
pubmed: 19443590
Cell Tissue Res. 2018 May;372(2):393-401
pubmed: 29450723
Clin Nucl Med. 2017 Dec;42(12):e491-e497
pubmed: 28902729
Cancer Res. 2008 Sep 1;68(17):7183-90
pubmed: 18757434
Radiol Oncol. 2014 Jul 10;48(3):228-34
pubmed: 25177236
J Clin Endocrinol Metab. 2013 Jul;98(7):2643-4
pubmed: 23671317
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1248-57
pubmed: 26637204
J Nucl Med. 2018 Jun;59(6):915-921
pubmed: 29191855
Theranostics. 2012;2(5):448-58
pubmed: 22768025
Br J Surg. 2012 Nov;99(11):1480-6
pubmed: 22972490
Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):67-77
pubmed: 19618183
Anticancer Res. 2014 Nov;34(11):6647-54
pubmed: 25368270
Ann Oncol. 2008 Oct;19(10):1727-33
pubmed: 18515795
Q J Nucl Med Mol Imaging. 2010 Feb;54(1):68-75
pubmed: 20168288
Ann Surg Oncol. 2015 Jan;22(1):164-71
pubmed: 25190113
J Clin Endocrinol Metab. 2009 Apr;94(4):1295-301
pubmed: 19141589
Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):409-18
pubmed: 25367749
Thyroid. 2009 Jun;19(6):565-612
pubmed: 19469690
Lancet Oncol. 2006 Sep;7(9):728-34
pubmed: 16945767
Eur J Nucl Med Mol Imaging. 2009 May;36(5):765-70
pubmed: 19137293
World J Surg. 2019 May;43(5):1232-1242
pubmed: 30659347
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1593-600
pubmed: 26923247
Clin Nucl Med. 2014 Dec;39(12):1033-8
pubmed: 25290292
Cancer Imaging. 2012 May 21;12:173-84
pubmed: 22743056
J Nucl Med. 2017 Sep;58(9):1452-1458
pubmed: 28280220
Nucl Med Mol Imaging. 2018 Apr;52(2):119-124
pubmed: 29662560
Surg Oncol Clin N Am. 2016 Jan;25(1):103-18
pubmed: 26610777
Cancer. 2013 Jan 1;119(1):36-44
pubmed: 22744914
Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2083-9
pubmed: 25063039
Ann Surg Oncol. 2012 Jul;19(7):2272-8
pubmed: 22437201
Otolaryngol Head Neck Surg. 2005 Mar;132(3):359-72
pubmed: 15746845
Eur J Surg Oncol. 2017 Jan;43(1):133-137
pubmed: 27776943
Eur J Nucl Med Mol Imaging. 2014 May;41(5):856-64
pubmed: 24435773
Eur J Nucl Med Mol Imaging. 2006 May;33(5):532-40
pubmed: 16491425
Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1144-53
pubmed: 22358431
Radiology. 1995 May;195(2):333-7
pubmed: 7724749
Neuroendocrinology. 2012;95(2):135-56
pubmed: 22262080
Ann Nucl Med. 2014 Aug;28(7):638-45
pubmed: 24862238
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1588-1601
pubmed: 28547177
J Clin Endocrinol Metab. 2014 Oct;99(10):3561-9
pubmed: 25162665
J Clin Endocrinol Metab. 2011 Mar;96(3):665-71
pubmed: 21193541
J Nucl Med. 2011 Dec;52(12):1855-63
pubmed: 22052128
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
Int J Mol Imaging. 2012;2012:324686
pubmed: 22852077
Eur J Endocrinol. 2016 Nov;175(5):485-498
pubmed: 27562400
J Nucl Med. 2008 Apr;49(4):524-31
pubmed: 18375923
Visc Med. 2017 Oct;33(5):324-330
pubmed: 29177160
Am J Surg. 2007 Feb;193(2):155-9
pubmed: 17236840
J Nucl Med. 2012 Dec;53(12):1863-71
pubmed: 23081996
Cancer Imaging. 2011 Jun 15;11:70-5
pubmed: 21697027
Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):78-84
pubmed: 12483413
Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):658-666
pubmed: 29270788
Lancet Oncol. 2008 Jan;9(1):61-72
pubmed: 18177818
J Nucl Med. 2006 Sep;47(9):1455-62
pubmed: 16954553
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2004-2013
pubmed: 28646462
Nat Rev Endocrinol. 2015 Feb;11(2):101-11
pubmed: 25385035
Radiology. 2017 Aug;284(2):460-467
pubmed: 28121522
Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):569-80
pubmed: 22223169
J Clin Oncol. 2008 Nov 10;26(32):5307-8; author reply 5308-9
pubmed: 18854556
J Nucl Med. 2010 May;51(5):704-12
pubmed: 20395333
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2318-2327
pubmed: 30054698
Abdom Imaging. 2015 Feb;40(2):299-309
pubmed: 25134801
Endocrine. 2012 Aug;42(1):80-7
pubmed: 22350660
Radiol Oncol. 2015 Nov 27;49(4):327-33
pubmed: 26834518
Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):637-43
pubmed: 17960377
Clin Nucl Med. 2012 Jun;37(6):593-5
pubmed: 22614195
J Clin Endocrinol Metab. 2003 Nov;88(11):5353-60
pubmed: 14602773
Curr Radiopharm. 2013 Jun 6;6(2):96-105
pubmed: 23745775
Thyroid. 2015 Jun;25(6):567-610
pubmed: 25810047
Lancet. 2018 Jan 13;391(10116):168-178
pubmed: 28923463
Eur J Surg Oncol. 2010 Apr;36(4):414-21
pubmed: 20100647
Osteoporos Int. 2017 Jan;28(1):1-19
pubmed: 27613721
J Clin Endocrinol Metab. 2005 Apr;90(4):2110-6
pubmed: 15644401
Neuroendocrinology. 2014;100(4):293-9
pubmed: 25301162
J Nucl Med. 2009 Dec;50(12):1927-32
pubmed: 19910422
Front Endocrinol (Lausanne). 2018 Jan 22;8:380
pubmed: 29403435
Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1977-95
pubmed: 22926712
Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1604-9
pubmed: 17435996
Clin Nucl Med. 2015 Aug;40(8):682-4
pubmed: 25549347
Thyroid. 2010 May;20(5):527-33
pubmed: 20450432
J Radiol Prot. 2018 Mar;38(1):343-356
pubmed: 29339573
Ann Nucl Med. 2018 Jan;32(1):7-15
pubmed: 28986764
J Nucl Med. 2016 Jun;57(6):872-8
pubmed: 26769864
Nucl Med Commun. 2016 Dec;37(12):1246-1252
pubmed: 27612033
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1762-1771
pubmed: 29516131
Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1027-33
pubmed: 26497699
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
Eur Radiol. 2018 Jun;28(6):2700-2707
pubmed: 29372312
Clin Nucl Med. 2012 Mar;37(3):245-51
pubmed: 22310250
Nucl Med Commun. 2002 Aug;23(8):727-34
pubmed: 12124477
J Nucl Med. 2017 Sep;58(Suppl 2):61S-66S
pubmed: 28864614

Auteurs

Sébastien Bergeret (S)

Sorbonne University, Nuclear Medicine Department, Pitié-Salpêtrière Hospital, 47-83 Bd de l'Hôpital, 75013, Paris, France.

Judith Charbit (J)

Sorbonne University, Nuclear Medicine Department, Pitié-Salpêtrière Hospital, 47-83 Bd de l'Hôpital, 75013, Paris, France.

Catherine Ansquer (C)

Nuclear Medicine Department, CHU-Hôtel Dieu, 1 Place Alexis Ricordeau, 44093, Nantes Cedex1, France.
CIRCINA INSERM, Angers University, 8 quai Moncousu, 44000, Nantes, France.

Géraldine Bera (G)

Sorbonne University, Nuclear Medicine Department, Pitié-Salpêtrière Hospital, 47-83 Bd de l'Hôpital, 75013, Paris, France.
INSERM U1146, Laboratoire d'imagerie Biomedicale (LIB), Sorbonne University, Paris, France.

Philippe Chanson (P)

Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, Le Kremlin Bicêtre, F-94275, France.
INSERM UMR S1185, Fac Med Paris Sud, Univ Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, F-94276, France.

Charlotte Lussey-Lepoutre (C)

Sorbonne University, Nuclear Medicine Department, Pitié-Salpêtrière Hospital, 47-83 Bd de l'Hôpital, 75013, Paris, France. charlotte.lussey@inserm.fr.
INSERM U970, Georges Pompidou European Hospital Cardiovascular Research Center, 56 rue Leblanc, 75015, Paris, France. charlotte.lussey@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Acides aminés › Acides aminés cycliques › Acides aminés aromatiques › Tyrosine › Dopa › Novel PET tracers: added value for endocrine disorders.
questionsmedicales.fr › Maladies endocriniennes › Novel PET tracers: added value for endocrine disorders.
questionsmedicales.fr › Glucides › Désoses › Désoxyglucose › Fluorodésoxyglucose F18 › Novel PET tracers: added value for endocrine disorders.
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Métaux lourds › Gallium › Isotopes du gallium › Radio-isotopes du gallium › Novel PET tracers: added value for endocrine disorders.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Novel PET tracers: added value for endocrine disorders.
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › Novel PET tracers: added value for endocrine disorders.
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Novel PET tracers: added value for endocrine disorders.
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Radiopharmaceutiques › Novel PET tracers: added value for endocrine disorders.